As expected, there were no obvious differences in weight change, colon length, colitis scores and the ratio of mesenteric weight to body weight between Il‐10−/– mice receiving miR‐132‐3p antagonized CrF‐EVs and untreated Il‐10−/– mice (Figure 6G–O and Figure S10). Here, IL10 is linked to colitis.